abstract: Morphological assessments are the main way in which fertility clinics select in vitro generated embryo(s) for transfer to the uterus.
Introduction
In the vast majority of IVF laboratories around the world, embryo selection is still based, for the most part, on morphological evaluation. Visual analyses are typically carried out at three distinct developmental stages: just after fertilization, at the cleavage stage and at the blastocyst stage (if undertaking extended embryo culture). The morphological criteria considered include the following: the number of pronuclei and polar bodies (zygotes); cell number, evenness of mitotic divisions, presence of micronuclei and amount of cellular fragmentation (cleavage embryos); extent of blastocoel expansion and quality of inner cells mass (ICM) and trophectoderm (TE) (blastocysts) (e.g. Cummins et al., 1986; Puissant et al., 1987; Van Royen et al., 1999; Gardner and Schoolcraft, 1999; Gianaroli et al., 2007; Stensen et al., 2010) . It is generally accepted, however, that the correlation between embryo morphology and implantation potential is relatively weak (Moyaeri et al., 2008; Alfarawati et al., 2011) . Even embryos considered to be morphologically perfect do not always succeed in implanting in the uterus. Conversely, an appreciable fraction of embryos of suboptimal microscopic appearance do produce healthy babies. In order to overcome deficiencies in embryo viability assessment, many IVF clinics worldwide opt to transfer more than one embryo in some cycles. Although this increases the probability of transferring a competent embryo, the risk of multiple pregnancies and associated medical complications is inevitably increased (Bromer and Seli, 2008) .
Aneuploidy is the principal genetic factor influencing human reproductive success. Prior to implantation, chromosome abnormality is extremely common, affecting more than half of all embryos produced by women over 35 years of age (Wells and Delhanty, 2000; . In most cases embryos affected by such abnormalities undergo developmental arrest or fail to implant (Scott et al., 2012) . Of those aneuploid embryos that succeed in establishing a pregnancy, the vast majority eventually miscarry, explaining why approximately two-thirds of spontaneous abortions are found to be chromosomally abnormal (reviewed in Nagaoka et al., 2012) .
Many studies have considered the relationship between embryo morphology and aneuploidy. One such investigation examined the number of cells at the cleavage stage and correlated it with embryonic chromosome constitution (Magli et al., 1998) . It was evident from the data obtained that embryos with delayed development (3-4 cells on Day 3) or those growing unusually fast (9 cells or more on Day 3) were at an elevated risk of being aneuploid (Magli et al., 1998) . Other investigations carried out at the cleavage stage have revealed associations between chromosome errors and the presence of cellular fragmentation, asymmetric divisions and multinucleated blastomeres (Hardarson et al., 2003; Munne et al., 2006) . More recently, Eaton et al. (2009) examined the relationship between embryo morphology on Day 3, aneuploidy and development to the blastocyst stage. They observed that, in general, embryos of superior morphological quality were more likely to be euploid for certain chromosomes, including X/Y, 8, 15, 16, 18 and 22, whereas other chromosomes such as 13, 20, or 21 did not show any obvious effect on either cleavage stage morphology or blastocyst development (Eaton et al., 2009) .
The aforementioned studies succeeded in proving that chromosomal abnormality and morphological grade are not entirely independent, although it was also clear that the relationship between the two is not absolute: embryos receiving the highest morphological scores were sometimes found to be abnormal, while those achieving poor grades were often characterized as euploid. Although these investigations yielded valuable data, they all utilized fluorescent in situ hybridization (FISH) to assess aneuploidy, a method that only permits a partial chromosomal assessment. Even the most detailed FISH-based studies evaluated fewer than half of the chromosomes in each embryo. As only limited numbers of chromosomes were examined, it is very likely that some of the embryos classified 'normal' were in fact aneuploid for chromosomes that were not tested, weakening the ability to detect associations between chromosomal anomalies and morphology.
Over the last few years, methods allowing simultaneous testing of all 24 types of chromosome in human embryos have become available and are increasingly widely applied for the purpose of preimplantation genetic screening (PGS) (e.g. Fragouli et al., 2010; Yang et al., 2012; Rubio et al., 2013; Scott et al., 2013) . The current investigation made use of one of these techniques to provide a sensitive evaluation of the impact of aneuploidy on embryo morphology at the cleavage (Day 3) and blastocyst (Day 5) stages. Particular attention was paid to the morphology of embryos carrying chromosome abnormalities of types that can be observed during later stages of gestation (i.e. potentially compatible with implantation, formation of a clinical pregnancy and in some cases a live birth, e.g. trisomy 21).
Materials and Methods

Details of analysed embryos
One thousand two hundred and thirteen embryos were included in this study: 355 cleavage-stage embryos from 64 patients (average female age 39.4 years, age range 27 -45 years) and 858 blastocysts from 161 patients (average female age 38.6 years, age range 29 -47 years). There was no significant difference in maternal age or any other clinical parameters for which data were available. The couples who generated these embryos were all undergoing PGS for various indications in several IVF clinics. Participating clinics had both ethical approval and appropriate clinical treatment licences in place. It should be noted that only viable embryos were examined during the course of this study. Embryos generated by these patients which either then arrested, or were not deemed suitable for biopsy, were not available for cytogenetic analysis. The ovarian stimulation protocols used were chosen by the physicians treating the patients, depending on clinical characteristics, but did not differ significantly from strategies considered to be routine.
Embryo scoring
Embryo morphology was assessed and recorded on Day-3 and -5 postfertilization. The referring IVF clinics assessed embryos using standard morphological criteria (Puissant et al., 1987; Steer et al., 1992; Gardner and Schoolcraft, 1999, Hardarson et al., 2001) . These criteria are outlined in Tables I and II. Comprehensive chromosome analysis using microarray comparative genomic hybridization
The 24 SureTM Cytochip (BlueGnome Ltd, Cambridge, UK) microarray platform was employed for the detailed assessment of chromosomes in cells from the embryos analysed during the course of this study. The protocol was as reported in Fragouli et al. (2013) . Briefly, the procedure included lysis and whole genome amplification of the embryonic material, followed by their Cy3 or Cy5 fluorescent labelling, hybridization along with normal male (46,XY) and female (46,XX) reference DNA samples, posthybridization washes, scanning and analysis of images. All these occurred with the use of reagents and as suggested by the manufacturer (BlueGnome Ltd, Cambridge, UK).
Image analysis and interpretation
A laser scanner (InnoScan 710, Innopsys, Carbonne, France) was used to obtain images from the microarray slides. This scanner was capable of exciting the Cy3 and Cy5 fluorophores, and of reading and storing the resulting hybridization images. Image analysis took place via a combination of the MAPIX software (Innopsys, Carbonne, France) 
Statistical analysis
The data obtained during the course of this study were analysed with the use of Fisher's exact test.
Results
The incidence of aneuploidy at the cleavage stage
Of the 355 cleavage stage embryos assessed, 58 (16%) were characterized as chromosomally normal and 297 (84%) were aneuploid. The aneuploid embryos were further categorized according to the number of chromosomes affected by malsegregation. Hence, 86 (29%) carried a single aneuploidy, 60 (20%) carried two aneuploidies and 151 (51%) carried 3 or more errors and were considered to be 'complex' abnormal. A total of 1262 individual chromosome abnormalities were scored in aneuploid cleavage stage embryos. Among them, 652 (52%) were losses and the remaining 610 were gains (48%). The vast majority (1188, 94%) of these errors affected entire chromosomes, but 74 (6%) were segmental imbalances, involving loss or gain of chromosomal fragments. The embryos were also assessed in relation to female age. Specifically, the samples were grouped into two different categories, according to the age of the women who generated them. The first category consisted of a total of 82 cleavage stage embryos generated by 13 reproductively younger women (average age: 33.6 years, age range: 27-36 years), and the second consisted of the remaining 273 embryos which were generated by 51 reproductively older women (average age: 41 years, age range: 37-45 years). Of the 82 embryos analysed for the younger patient group, 22 (27%) were seen to be euploid and the remaining 60 (73%) were aneuploid. For the older group, 36 (13%) of all examined embryos were euploid, whereas chromosome errors were scored for the other 237 (87%). The difference seen in aneuploidy rates between the younger and older groups of women was highly statistically significant (P ¼ 0.006).
The effect of aneuploidy on embryo development to the cleavage stage A total of 273 (77%) of Day-3 embryos were classified as 'good' quality. Of the remaining embryos, 61 (17%) were classified as 'average' and 21 (6%) were considered to be of 'poor' quality. The morphological criteria used for this classification are outlined in Table I , whereas the correlation between cleavage stage morphology and embryo chromosome status is described in Table III .
Of the good quality embryos that were found to be aneuploid, 119/ 273 (43.4%) were characterized as complex abnormal, while 63/273 (23%) were affected by a single error and 43 (16%) carried 2 errors. The obtained data clearly show that embryos achieving the best morphological scores, the types preferred for transfer to the uterus, remain at high risk of aneuploidy. It was also evident from our data that complex chromosome errors were present in embryos of all morphological grades. These findings are summarized in Table III and are illustrated in Fig. 1 .
A normal sex chromosome complement was scored for a total of 302 cleavage stage embryos (euploid and aneuploid). Of these 177 (59%) were female and 125 were male (41%). Interestingly, there was a tendency for female embryos to develop faster than their male counterparts: 11.3% (20) of the female embryos consisted of 10 or more cells at the time of morphological evaluation, whereas 5.6% (7) male embryos were at the same stage. This difference approached statistical significance (P ¼ 0.065). There was no increase in the incidence of aneuploidy related to a specific sex. These findings are summarized in Table IV .
The morphology of aneuploid embryos carrying types of chromosome error most often associated with the formation of a clinical pregnancy (i.e. trisomies 13, 16, 18, 21 and 22, and sex chromosome abnormalities) was also evaluated. Specifically, comparisons took place between 18 embryos with such aneuploidies, 58 euploid embryos and 100 embryos carrying single trisomies affecting other chromosomes or single monosomies. Statistical analysis of the data indicated that morphological scores were no different, regardless of whether a cleavage stage (Gardner and Schoolcraft, 1999 embryo was euploid, affected by a type of aneuploidy capable of pregnancy formation, or carrying a single aneuploidy of a type never seen during pregnancy (P ¼ 0.14 and P ¼ 0.6, respectively). This set of data is shown in Table V and Fig. 2 .
The incidence of aneuploidy at the blastocyst stage
A total of 858 blastocysts were also assessed. A normal chromosome complement was identified for 373 (44%) of them, while abnormalities were detected for the remaining 485 (56%). Unlike the cleavage stage, only a small minority of aneuploid blastocysts (79, 16%) were characterized as complex abnormal. 59% (284) were affected by a single chromosome error and 25% (122) had two errors. A total of 870 abnormalities were detected. Most of these (801) affected entire chromosomes, but 7.9% of errors (69) involved segmental abnormalities. Similar to the cleavage stage, 449 (52%) of all abnormalities were chromosome losses and 421 (48%) were gains. The incidence of aneuploidy at the blastocyst stage was also evaluated in relation to female age. A total of 286 embryos were generated by 44 reproductively younger women (average age: 33.5 years, age range: 29 -36 years). Among them, 156 (55%) were characterized as normal, whereas chromosome malsegregation errors were scored for 130 (45%). Five hundred and seventy-two blastocysts were generated by 117 reproductively older women (average age: 40.5 years, range: 37-47 years). Fewer blastocysts were euploid (217, 38%) for this patient group, with the majority being chromosomally abnormal (355, 62%). As with the cleavage stage, the difference seen in aneuploidy rates between blastocysts from younger and older women was highly statistically significant (P ¼ 0.0016).
The effect of aneuploidy on embryo development to the blastocyst stage A total of 122 (14.2%) of the embryos assessed at the blastocyst stage were well developed (Grade 5 or 6) on Day 5, 642 (74.8%) were considered to be average (Grade 3 or 4) and 94 (11%) were early (i.e. blastocoel cavity not fully expanded, Grade 1 or 2). The morphological criteria used to classify these embryos, according to the extent of development and degree of blastocoel expansion, are summarized in Table II analysis showed that 62/122 (51%) of the fully expanded (Grade 5 or 6) blastocysts were chromosomally normal, whereas only 33% (31/94) of the early (Grade 1 or 2) blastocysts were characterized as euploid. It was therefore evident that euploid embryos tend to show a faster progression to the most advanced expansion stages when compared with aneuploid embryos (P ¼ 0.012). Interestingly, the incidence of multiple errors was twice as high in the early blastocysts (affecting 14%), compared with those that had achieved full expansion (6%). A summary of these data is shown in Table VI and is illustrated in Fig. 3 .
Morphologic evaluation of the ICM revealed that it tended to be affected by the presence of chromosome errors in the embryo, although this did not reach statistical significance (P ¼ 0.3). A tightly packed ICM with many cells (Grade A) was observed in 51% (172 out of 337 with ICM grading) of normal embryos compared with 45% (181 out of 406 with ICM grading) of aneuploid embryos. The data obtained also indicated that ICM quality was highly dependent on the number of chromosome abnormalities, with the ratio of euploid:complex aneuploid decreasing with declining ICM quality (Grade A, 11:1; Grade B, 4:1; Grade C, 3:1). In other words, complex aneuploid blastocysts generally had ICMs of poorer morphology, compared with those of euploid embryos.
Similar to the ICM observations, blastocysts achieving the best quality TE scores (Grade A-many cells forming a cohesive epithelium) had a greater chance of being euploid than those of poorer grades. Specifically, 137/337 (41%) of normal blastocysts had a Grade A TE, compared with 115/406 (28%) of those with errors, and this difference was statistically significant (P ¼ 0.002). Additionally, decreasing TE quality was associated with an increase in the incidence of complex aneuploidy (ratio euploid:complex: Grade A, 15:1; Grade B, 4:1; Grade C, 4:1). A more detailed description of the ICM and TE data is shown in Tables VII  and VIII. Of the 795 blastocysts with a normal sex chromosome complement, males and females were observed in equal incidence; 392 (49.3%) were male and 403 (50.7%) were female. However, a small excess of male embryos over females (56 versus 44%, respectively) was observed for the most developed blastocysts (Grades 5 and 6). On the contrary, in the case of slower growing (Grade ≤ 3) blastocysts, female embryos predominated over males (52 versus 48%). It should be noted that neither of these gender differences were statistically significant (P ¼ 0.15 and 0.9, respectively). No correlation was seen between the gender of the blastocyst and the incidence of aneuploidy. A summary of these data is shown in Table IX .
The morphology and growth rate of 87 aneuploid blastocysts carrying varieties of abnormality with the greatest potential for implantation and clinical pregnancy (i.e. trisomies 13, 16, 18, 21 and 22, and sex chromosome abnormalities) were compared with those of the 373 euploid blastocysts and with 190 embryos carrying a single chromosome error not capable of leading to clinically recognized pregnancies (e.g. affecting larger chromosomes). Among the faster growing embryos (expansion (60) 49 (12) 406 (100) Aneuploid/1 error 82 (20) 132 (33) 25 (6) Aneuploid/2 errors 24 (6) 62 (15) 17 (4) Complex aneuploid 9 (2) 48 (12) 7 (2) clinical pregnancy occurred at approximately the same frequency as those that were chromosomally normal (19.5 and 17%, respectively). Aneuploid embryos affected by a single anomaly, incompatible with a clinical pregnancy, formed blastocysts of top morphological quality at a lower rate (13%), although the difference was not statistically significant. When the morphology of the ICM and the TE were compared for the three groups of embryos, it was evident that blastocysts carrying errors which could lead to clinical pregnancies were indistinguishable from euploid blastocysts (ICM A/B euploid versus aneuploid, 86 versus 90%, respectively; ICM C/early, 14 versus 10%; TE A/B, 82 versus 83%; TE C/early, 18 versus 17%). However, embryos with chromosome abnormalities incompatible with clinical pregnancy generally had ICM and TE of poorer quality, compared with the other two groups (ICM A/B, 76%; ICM C/early, 24%; TE A/B, 72%; TE C/early, 28%). These differences were statistically significant (P ¼ 0.003 for ICM and P ¼ 0.01 for TE). These results are shown in Tables X, XI and XII and Fig. 4 .
Discussion
During the first few days of life, the genome is essentially silent, the embryo surviving on stored mRNA and proteins derived from the oocyte, and consequently genetic abnormalities may remain hidden. Once the resources provided by the oocyte become depleted, the embryo must begin expressing its own genes if it is to progress any further. Genome activation usually takes place when the embryo consists of 4-8 cells (Braude et al., 1988) . As the embryonic genome begins to take control, the effects of any genetic abnormalities are likely to be felt increasingly strongly and may potentially start to influence aspects of embryo morphology. In theory, key developmental processes occurring after genome activation, such as compaction, cellular differentiation leading to formation of the ICM and TE and coordination of cells to form an ordered blastocyst, could be perturbed by the presence of genetic abnormalities. For this reason a morphological analysis after genome activation at later preimplantation stages (e.g. blastocysts) may be particularly valuable. A previous study, examining the effect of chromosome abnormalities on preimplantation development, postulated that aneuploid or mosaic embryos have an increased likelihood of undergoing developmental arrest before compaction occurs (Rubio et al., 2007) . Recent investigations by our group and others have confirmed that the incidence of chromosome abnormalities does decline during progression to the blastocyst stage, most likely due to demise of aneuploid embryos (Fragouli et al., 2013) . However, it is clear that only a minority of chromosomally abnormal embryos suffer this fate (reviewed in ). In the current study, the aneuploidy rate dropped significantly from 84% at the cleavage stage to 56% at the blastocyst stage (P , 0.0001). It should be noted that the well-documented effect of maternal age on aneuploidy rates was clearly evident for both of the developmental stages examined, with abnormality rates steeply increasing in embryos generated by older women. The effect of age was particularly apparent among blastocysts, with aneuploidy increasing from 45% for an average maternal age of 33.5 to 62% at an average age of 40.5 years (P ¼ 0.0016).
At the cleavage stage, aneuploidy rates were remarkably high, even for reproductively younger women (73% for average female age 33.6 years) and reached 87% for the older group of patients (averaging 41 years of age). High aneuploidy rates have previously been observed in other investigations involving comprehensive cytogenetic analysis of cleavage stage embryos (Wells and Delhanty, 2000; Voullaire et al., 2000; Northrop et al., 2010; Gutierrez-Mateo et al., 2011; Fragouli et al., 2013; Mertzanidou et al., 2013) . Considering that chromosome abnormalities occur relatively infrequently in sperm (affecting 5%) (Carrell et al., 2003; Petit et al., 2005) , and as the possible false-positive rate for the aCGH (83) 15 (17) Non-viable single abnormalities 138 (72) 52 (28) methodology does not exceed 2.7% , the high prevalence of aneuploidy at the cleavage stage is likely due to a combination of oocyte and post-zygotic malsegregation errors (Fragouli et al., 2013) . In the younger patient group, between one-fifth and one-third of oocytes would be expected to harbour a meiotic chromosome abnormality and thus approximately half of all of the aneuploidies seen at the cleavage stage are likely to be of mitotic origin. This finding is concordant with numerous studies reporting a high rate of chromosomal mosaicism amongst human cleavage stage embryos, indicative of mitotic errors occurring during the first few divisions following fertilization. Various investigations using FISH to examine aneuploidy and morphology at the cleavage stage have suggested a weak correlation between the two (e.g. Hardarson et al., 2003; Eaton et al., 2009) . However, such studies were incapable of categorically defining embryos as euploid or chromosomally abnormal due to the limitations of the FISH method. The current study employed molecular cytogenetic methodology. This meant that we were capable not only of examining the entire chromosome complement, but distinguishing between normal and aneuploid embryos with much more certainty. Yet despite the improved methodology, the results obtained were broadly in agreement with the earlier studies. Aneuploidy was found to have little effect on the morphology of the majority of cleavage stage embryos. Hence, aneuploid embryos were classified as having good morphology almost as often as those that were chromosomally normal (72 versus 83% at the cleavage stage). This highlights the fact that the type of embryos preferred for transfer to the uterus based upon their morphological appearance are often abnormal. The remarkable ability of cleavage stage embryos to tolerate aneuploidy was further emphasized by the fact that more than half of the complex abnormal embryos (having three or more chromosome errors) also achieved good morphological grades. Only embryos of the very poorest morphology had any noticeable difference in the aneuploidy rate (P ¼ 0.0019). However, poor quality embryos were sometimes found to be euploid, demonstrating that even at the extreme end of the morphological scale the association between microscopic appearance and chromosomal status remains weak. Blastocyst morphology showed a slightly stronger link to aneuploidy. Approximately 50% of embryos with fully expanded blastocoel cavities were chromosomally normal, compared with about one-third of early blastocysts. The presence of chromosome abnormalities not only affected the rate of expansion on Day 5, but the quality of the ICM and TE as well. Both these components of the blastocyst showed a declining quality in relation to aneuploidy, although this was much more evident for the TE. These findings are in agreement with our previous investigation and confirm the adverse effect of chromosome No morphological differences were observed between euploid blastocysts and those carrying possibly viable single trisomies. However, blastocysts carrying single non-viable errors were as a whole of poorer quality, compared with the other two groups. These differences were statistically significant for ICM (P ¼ 0.003) and TE (P ¼ 0.01).
errors especially after activation of the embryonic genome. A direct relationship between TE quality and clinical outcome has been described recently (Honnma et al., 2012) . Specifically, blastocysts with TE of Grades B and C were at a higher risk of not implanting or miscarrying, compared with those with TE of Grade A. Our findings suggest that increased aneuploidy risk may be the underlying reason for this observation.
It has been shown previously that the timing of cleavage divisions is of crucial importance and that faster development could be associated with aneuploidy . Recently, new systems have been developed which enable a detailed analysis of embryonic cleavage divisions with the use of time-lapse imaging. Careful measurement of morphokinetic data has allowed the creation of novel algorithms predictive of development to the blastocyst stage, behaviour after biopsy and clinical outcome (Meseguer et al., 2011; Cruz et al., 2012; Kirkegaard et al., 2012; Chavez et al., 2013; Wong et al., 2013) .
An important question is whether or not time-lapse systems will be capable of providing an insight into aneuploidy. Can the soft association between static morphological scoring and aneuploidy be hardened into a clinically useful diagnostic via the development of specially designed algorithms? A recent study carried out by Campbell et al. (2013) defined a time-lapse algorithm which may be able to identify some types of chromosome abnormalities. However, the results on time-lapse detection of aneuploidy were not definitive with 30% of the embryos considered to have 'low' aneuploidy risk subsequently found to be abnormal using aCGH and 30% of embryos with 'medium' risk identified as euploid (Campbell et al., 2013) . In virtually all somatic cells, errors that have the potential to produce aneuploidy, such as misalignment of chromosomes at metaphase or abnormalities of the mitotic spindle, induce a delay to the cell cycle. Since cleavage stage embryos often fail to segregate their chromosomes correctly during mitosis, leading to chromosomal mosaicism, alterations in the duration of specific phases of the cell cycle might be expected in some cases. It seems particularly likely that complex abnormal embryos, which are usually highly mosaic, often suffering from chaotic division of chromosomes, would suffer significant distortions to the cell cycle. However, it is not clear whether time-lapse analysis could identify embryos with more subtle abnormalities (e.g. single aneuploidies), especially those arising during meiosis. Meiotic aneuploidies, involving single chromosomes, are the most common type of anomaly seen in miscarriages and prenatal samples (reviewed in Nagaoka et al., 2012) and may therefore be considered of the greatest clinical importance, yet the abnormal cell divisions that produce such errors occur prior to the time when most time-lapse evaluations have been undertaken.
While complex abnormal embryos were confirmed to have a greatly reduced probability of reaching the most expanded blastocyst stages compared with euploid ones (P , 0.0001), embryos affected by aneuploidies of chromosomes 13, 16, 18, 21 and 22 were morphologically indistinguishable from those of normal embryos, during both examined stages. It seems that these particular chromosome abnormalities are not selected against during preimplantation development. This finding is consistent with the fact that conceptions with aneuploidy affecting one of these chromosomes are often capable of implanting and producing clinical pregnancies, usually ending in miscarriage (Menasha et al., 2005) . Aneuploidies compatible with implantation do not seem to disrupt early development, have no effect on standard morphological grading, and it seems likely that they may be difficult if not impossible to detect using time-lapse methods.
An interesting observation was that at the cleavage stage, females were overrepresented among the fastest growing embryos (10 or more cells), while at the blastocyst stage the trend was reversed, with a small excess of male embryos amongst the most expanded blastocysts. The reason behind these sex-related differences at the two developmental stages is not clear at this time. Data obtained during a study carried out by Burgoyne (1993) suggested that the presence of a Y chromosome could have a positive influence on development due to the expression of growth factor genes taking place after embryonic genome activation. It has also been postulated that the process of X chromosome inactivation occurring in female embryos could influence their growth relative to males (Van den Berg et al., 2009) . Differences in developmental rates related to the sex of the embryo may also have important implications on the assessment of embryo competence based upon timing of the phases of the cell cycle, potentially complicating time-lapse analysis.
In summary, the use of methods providing a comprehensive analysis of chromosomes at the cleavage and blastocyst stages has confirmed that aneuploidy has relatively little impact on morphology. Generally, only the most severe forms of aneuploidy (multiple and/or large gene-rich chromosomes) have a significant influence on the microscopic appearance of preimplantation embryos. Transferring cleavage or blastocyst stage embryos of high morphological quality can lead to a slight reduction in aneuploidy risk, helping to avoid complex abnormal embryos in particular. However, the benefits are relatively small and morphological selection is completely ineffective for avoiding the types of aneuploidy capable of producing a clinical pregnancy.
It is possible that in the future time-lapse methods of embryo evaluation may lead to enhanced detection of aneuploidy during preimplantation development. However, this remains to be proven and it seems likely that many forms of meiotic abnormality will remain invisible to such analyses. Currently, the only reliable way to avoid the transfer of aneuploid embryos remains biopsy, ideally performed at the blastocyst stage, followed by analysis with the use of comprehensive chromosome screening methods. The clinical application of such methods for the purposes of PGS has recently led to promising clinical results in randomized controlled trials (Yang et al., 2012; Scott et al., 2013; Forman et al., 2013) .
